More uncertainty about acetaminophen effectiveness for low back pain and osteoarthritisPractice guidelines should reconsider recommending acetaminophen first-line in these situations. Clinical Feature: Rheumatoid arthritisA focus on new therapies and risk management. Rheumatoid arthritis: Effective disease control cuts mortality Biologics may offer an advantage over conventional disease-modifying drugs Rheumatologists and their patients leery of subsequent-entry biologics Researcher cites lack of North American trials as a concern Arthritis Research Centre of Canada receives CIHR Partnership Award for arthritis screening program Osteoporosis: Better drugs needed Bone density falls despite long-term oral bisphosphonate therapy Rheumatoid arthritis: Triple-drug combo could save millions Treatment is just as effective as a biologic, while much cheaper Celebrex generics now launching in Canada Health Canada approves several generic versions of celecoxib. Gout linked with increased diabetes risk Study supports proper recognition and management of risk factors, researchers say Tapered therapy maintains remission in rheumatoid arthritis Strategy addresses safety and cost concerns, but requires vigilant monitoring First Previous 12 13 14 15 16 Next Last
